Article
Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia
1 Aug 2010
Abstract excerpt
Allogeneic hemopoietic stem cell transplantation (HSCT) represents one of the best cures for thalassemia. Currently, HSCT for thalassemia consists of allogeneic stem cell gene therapy and still awaits autologous genetically modified stem cell transplantation. HSCT for thalassemia has substantially improved over the last two decades, due in large part to improvements in preventive strategies, the effective control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
